Literature DB >> 20087206

Effect of corticosteroid usage combined with multidrug therapy on nerve damage assessed using nerve conduction studies: a prospective cohort study of 365 untreated multibacillary leprosy patients.

Gospi Dolly Capadia1, Vanaja Prabhakar Shetty, Fatema Abbas Khambati, Sunil Dattatraya Ghate.   

Abstract

The purpose of this study is to determine the extent of nerve involvement and to study the effect of corticosteroids combined with multidrug therapy on nerve damage in leprosy patients using sensory and motor nerve conduction studies. A cohort of 365 untreated multibacillary leprosy patients were prospectively studied using sensory and motor nerve conduction studies on upper and lower limb nerves. They were subgrouped as those to be treated with 12-week regimen of corticosteroids for reaction and/or neuritis or silent neuropathy of <6 months duration along with 12-month multidrug therapy (group A), and those with no reaction were treated with multidrug therapy only (group B). Analysis was performed using SPSS version 10.0. Significance of association was tested using chi(2) test. At registration, abnormality by nerve conduction studies was seen in 92% of patients and majority (65%) showing involvement of more than five sensory and motor nerves. Sensory nerve abnormalities were higher (52%) than motor (37%) (P < 0.001). Affection of sensory and motor nerves was higher in group A (P < 0.001). Notably, 40% nerves in group B also showed impairment at 0 month. This implies that almost all patients showed abnormal nerve conduction studies at onset regardless of reaction, proving nerve damage is more widespread than envisaged. At 18 months, overall percentile deterioration (23%) of nerves was higher than improvement (9%) (P < 0.001) indicating that corticosteroids combined with multidrug therapy failed to significantly improve the nerve status. Sensory nerve (57%) affection was significantly higher than motor (46%) (P < 0.001). Moreover, percentile deterioration of sensory nerves was higher in group A (P < 0.001) implying corticosteroids is not very efficacious in the prevention or reversal of nerve damage. Electrophysiological tests provide valuable information for detecting nerve function impairment and evaluating appropriate therapeutic regimens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20087206     DOI: 10.1097/WNP.0b013e3181cb426d

Source DB:  PubMed          Journal:  J Clin Neurophysiol        ISSN: 0736-0258            Impact factor:   2.177


  5 in total

1.  Progression of leprosy neuropathy: a case series study.

Authors:  Robson T Vital; Ximena Illarramendi; Osvaldo Nascimento; Mariana A Hacker; Euzenir N Sarno; Marcia R Jardim
Journal:  Brain Behav       Date:  2012-05       Impact factor: 2.708

2.  Ultrasonography of Leprosy Neuropathy: A Longitudinal Prospective Study.

Authors:  Helena Barbosa Lugão; Marco Andrey Cipriani Frade; Wilson Marques; Norma Tiraboschi Foss; Marcello Henrique Nogueira-Barbosa
Journal:  PLoS Negl Trop Dis       Date:  2016-11-16

3.  Peripheral nerve abnormality in HIV leprosy patients.

Authors:  Marilia Brasil Xavier; Mariana Garcia Borges do Nascimento; Keila de Nazare Madureira Batista; Danusa Neves Somensi; Fernando Octavio Machado Juca Neto; Thomaz Xavier Carneiro; Claudia Maria Castro Gomes; Carlos Eduardo Pereira Corbett
Journal:  PLoS Negl Trop Dis       Date:  2018-07-18

4.  Evaluation of altered patterns of tactile sensation in the diagnosis and monitoring of leprosy using the Semmes-Weinstein monofilaments.

Authors:  Marco Andrey Cipriani Frade; Fred Bernardes Filho; Claudia Maria Lincoln Silva; Glauber Voltan; Filipe Rocha Lima; Thania Loyola Cordeiro Abi-Rached; Natália Aparecida de Paula
Journal:  PLoS One       Date:  2022-08-10       Impact factor: 3.752

5.  Two randomized controlled clinical trials to study the effectiveness of prednisolone treatment in preventing and restoring clinical nerve function loss in leprosy: the TENLEP study protocols.

Authors:  Inge Wagenaar; Wim Brandsma; Erik Post; Wim van Brakel; Diana Lockwood; Peter Nicholls; Paul Saunderson; Cairns Smith; Einar Wilder-Smith; Jan Hendrik Richardus
Journal:  BMC Neurol       Date:  2012-12-18       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.